—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
肿瘤营养学杂志(英文)(Journal of Nutritional Oncology)(不收版面费审稿费)
CN外文 - 季刊
  • 肿瘤营养学杂志(英文)(Journal of Nutritional Oncology)(不收版面费审稿费)
  • 复合影响因子:0.609
  • 国级普刊
  • 知网,万方,维普
  •  
  投稿方式:官网投稿
  • 栏目频次
  • 一作占比
  • 单位占比
  • 热词
暂无栏目信息.
暂无一作信息.
暂无单位信息.
暂无关键词信息.
  • 更多

    期刊简介

  • 《肿瘤营养学杂志(英文)》(Journal of Nutritional Oncology)(季刊),由国家卫生健康委员会主管,人民卫生出版社有限公司主办。期刊旨在反映肿瘤代谢、营养和营养干预方面的基础、临床和转化研究的最新发现,发表该领域的前沿科学研究。JNO致力于将肿瘤营养学这门新科学建设成为连接营养学和肿瘤学的桥梁,促进营养学和肿瘤生物学的基础研究最新进展转化为临床肿瘤学中的患者综合治疗。发表原创性研究论文、综述、病例报道、社论、简短通讯、观点和专题类文章。

  • 基本信息

  • 期刊名称:肿瘤营养学杂志(英文)(Journal of Nutritional Oncology)(不收版面费审稿费)
  • 主管单位:国家卫生健康委员会
  • 主办单位:人民卫生出版社有限公司
  • 国内刊号:CN 10-1448/R
  • 国际刊号:ISSN 2096-2746
  • 出刊日期:
    期刊定价:
  • 邮发代码:
  • 所在省区:北京
    邮政编码:
  • 联系地址:

  • 投稿信息

  • 学科分类:肿瘤学
    版面费用:不收版面费
  • 字数要求:12000-16000
    查重要求:-
  • 复合因子:0.609
    综合因子:0.565
  • 审  稿 费:
    稿费:待核实
  • 本刊可发:
  • 特殊属性:外文期刊

  • 联系方式

  • 投稿网址:https://www.editorialmanager.com/jnutroncol
  • 官网网址:https://journals.lww.com/jno
  • 电话传真:010-63926987;0771-5358436(202504期)
  • 电子邮箱:jno@nutroncol.org(202504期)
  • 微信公众号:JNO肿瘤营养学

审稿时间:暂无参考数据,审稿时间不确定!

投稿难度:网友分享,仅供参考

见刊周期:-

温馨提示以上只是参考信息,实际情况会根据投稿主题、稿件质量和数量、审稿流程有所差异。想获得更准确信息请联系期刊的编辑部进行咨询。

欢迎点评!让信息更透明,使投稿更轻松!
    • 审稿时间:
      是否录用:
    • 发表排期:
      查重要求:
    • 有无课题:
      有无回复:
    • 我的学历:
      我的职称:
    • 审稿费用:
      版面费用:
    • 稿       费:
      稿件字数:
    • 投稿难度:
    • 该刊可发:
    • 投稿主题:
匿名: 验证码: 点击切换验证码
    • 1、投稿方式:在线投稿。

      2、刊内网址(202504期):

      https://journals.lww.com/jno

      3、投稿系统:

      https://www.editorialmanager.com/jnutroncol

      4、刊内邮箱:jno@nutroncol.org

      5、刊内电话:010-63926987;0771-5358436

      6、出刊日期:季刊,逢季中月15日出版。

      7、官方微信公众号:JNO肿瘤营养学

      8、官网信息:不收版面费审稿费。

      2026年1月9日星期五

      Instruction For Authors

      【官网信息】

      The

      Editorial Office is pleased to answer any questions you may have about

      preparing your manuscript in accordance with our guidelines.

      Editorial Office contact:

      • Contact Email:  jno@nutroncol.org

      AIMS AND SCOPE

      The

      Journal of Nutritional Oncology (JNO) is an international, open-access,

      peer-reviewed academic journal that aims to reflect the latest findings

      in basic, clinical, and translation research in cancer metabolism,

      nutrition, and nutritional intervention. It publishes edge-cutting

      scientific studies in the field. It reports recent development and

      advances to its audience.

      First

      launched in 2016, JNO strives to encourage studies and progress in

      nutritional oncology, as the role of nutrition in cancer prevention and

      treatment draws an increasing spotlight.

      The scope of the Journal is but not limited to the following:

      -Study on cancer-related metabolism and nutrition

      -Basic studies on cancer, including etiology, pathogenesis, pathophysiology, and prevention strategies;

      -Prevention, diagnosis, treatment, rehabilitation, and chronic disease management of nutritionally related diseases;

      -Studies on public health related to epidemiology, prevention, monitoring, and health policy of nutritionally related diseases;

      -Translational science related to nutritional oncology;

      -Interdisciplinary research focusing on nutritional oncology.

      ONLINE SUBMISSION

      First-time Users

      Please

      click the Register button at

      https://www.editorialmanager.com/jnutroncol/default2.aspx. Upon

      successful registration, you will be sent an email providing your

      username and password. Save this information for future reference.

      Note:

      If you have received an email from us with an assigned username and

      password, or if you are a repeat user, do not register again. Once you

      have an assigned username and password, you do not have to re-register.

      Authors

      Please

      click the Login button from the menu at the top of the page and login

      to the system as an author. Submit your manuscript according to the

      author instructions. You will be able to track the process of your

      manuscript through the system.

      JOURNAL POLICIES

      Duplicate Publication

      Manuscripts

      are reviewed for possible publication with the understanding that they

      are being submitted only to the JNO and have not been published,

      simultaneously submitted, or already accepted for publication elsewhere.

      The Editorial team may subject any manuscript submitted for

      consideration of publication in the JNO to plagiarism-detection

      software.

      This

      does not preclude consideration of a manuscript that has been rejected

      by another journal or a complete report that follows publication of

      preliminary findings elsewhere, usually in the form of an abstract.

      Copies of any possibly duplicate published material should be submitted

      with the manuscript under consideration, with a statement in the cover

      letter as to why the manuscript currently being submitted is not a

      duplicate publication.

      Authorship

      JNO

      expects that each person listed as an author has participated

      sufficiently in the intellectual content, the analysis of data, and/or

      the writing of the manuscript to take public responsibility for it. Each

      author must have reviewed the manuscript, believes it represents valid

      work, and approves it for submission.

      Moreover,

      should the Editorial team request the data upon which the manuscript is

      based, the authors shall produce it. Each author's specific

      contributions to the work should be indicated; this information will be

      published as a footnote to the paper. For example, the areas of

      participation might include:

      Participated in research design

      Participated in the writing or critical revision of the paper

      Participated in the performance of the research

      Contributed new reagents or analytic tools

      Participated in data analysis

      An

      author may list more than one contribution, and more than one author

      may have contributed to the same aspect of the work. Any change in

      authorship/contributions after submission must be approved in writing by

      all authors and submitted to the Editorial Office for final

      consideration.

      An

      author may list more than one contribution, and more than one author

      may have contributed to the same aspect of the work. Any change in

      authorship/contributions after submission must be approved in writing by

      all authors and submitted to the Editorial Office for final

      consideration.

      Plagiarism

      As

      defined by the World Association of Medical Editors

      (http://www.wame.org/resources/publication-ethics-policies-for-medical-journals),

      plagiarism is the use of others' published and unpublished ideas or

      words (or other intellectual property) without attribution or

      permission, and presenting them as new and original rather than derived

      from an existing source. The intent and effect of plagiarism is to

      mislead the reader as to the contributions of the plagiarizer. This

      applies whether the ideas or words are taken from abstracts, research

      grant applications, Institutional Review Board applications, or

      unpublished or published manuscripts in any publication format (print or

      electronic).

      JNO

      is a member of CrossCheck by CrossRef and iThenticate. iThenticate is a

      plagiarism screening service that verifies the originality of content

      submitted before publication. iThenticate checks submissions against

      millions of published research papers, and billions of web content.

      Authors, researchers and freelancers can also use iThenticate to screen

      their work before submission by visiting http://www.ithenticate.com.

      All

      allegations of plagiarism are investigated in accordance with the

      Committee on Publication Ethics (COPE) guidelines detailed at

      https://publicationethics.org/files/u7140/plagiarism%20A.pdf. When

      plagiarism is detected at any time before or after publication, the

      journal editorial office will take appropriate action as directed by the

      standards set forth by COPE. If plagiarism is found, the author, the

      author's institution and funding agencies, and the original publication

      will be notified. A statement noting the plagiarism, providing a

      reference to the plagiarized material, and linking to the original paper

      may follow. Depending on the extent of the plagiarism, the paper may

      also be formally retracted. For additional information, please visit

      http://www.publicationethics.org.

      Financial Support and Disclosure of Conflicts

      Authors

      must state all possible conflicts of interest in the manuscript,

      including financial, consultant, institutional and other relationships

      that might lead to bias or a conflict of interest. If there is no

      conflict of interest, this should also be explicitly stated as none

      declared. All sources of funding should be acknowledged in the

      manuscript.

      All

      relevant conflicts of interest and sources of funding should be

      included on the title page of the manuscript with the heading "Competing

      interests" and “Funding".

      For

      example: “Competing interests: A has received honoraria from Company Z.

      B is currently receiving a grant (#12345) from Organization Y, and is

      on the speaker's bureau for Organization X - the CME organizers for

      Company A. For the remaining authors none were declared."

      “Funding": list all the grant supports/funders for the study.

      A

      financial disclosure section is part of the submission process and must

      be completed by each author at first revision. This information is for

      review by the Editors but will be published if relevant to the content

      of the accepted manuscript.

      The

      primary purpose of the disclosure section is to determine whether

      authors have received any commercial financial support that could create

      a conflict of interest. In addition to monetary interests, a potential

      for conflict of interest can exist whether or not an individual believes

      that a relationship (such as dual commitments, competing interests, or

      competing loyalties) affects his or her scientific judgment. Please

      review ICMJE Uniform Requirements for Manuscripts Submitted to

      Biomedical Journals at the following link:

      https://www.icmje.org/disclosure-of-interest/.

      Ethics

      When

      reporting studies on human subjects, author should indicate whether the

      procedures followed were in accordance with the ethical standards of

      the responsible committee on human experimentation (institutional or

      regional) and with the Declaration of Helsinki

      (https://www.wma.net/policies-post/wma-declaration-of-helsinki/). For

      prospective studies involving human participants, authors are expected

      to mention about approval of regional/national/institutional or

      independent ethics committee or review board, obtaining informed consent

      from adult research participants and obtaining assent for children aged

      over 7 years participating in the trial. The age beyond which assent

      would be required could vary as per regional and/or national guidelines.

      Ensure confidentiality of subjects by desisting from mentioning

      participants' names, initials or hospital numbers, especially in

      illustrative material. When reporting experiments on animals, indicate

      whether the institution's or a national research council's guide for, or

      any national law on the care and use of laboratory animals was

      followed.

      Evidence

      for approval by a local ethics committee (for both human as well as

      animal studies) must be supplied by the authors on demand. Animal

      experimental procedures should be as humane as possible, and the details

      of anesthetics and analgesics used should be clearly stated. The

      ethical standards of experiments must be in accordance with the

      guidelines provided by the ARRIVE and World Medical Association

      Declaration of Helsinki on Ethical Principles for Medical Research

      Involving experimental animals and human beings, respectively. The

      journal will not consider any paper which is ethically unacceptable. A

      statement on ethics committee permission and ethical practices must be

      included in all research articles under the “Methods" section.

      We

      reserve the right to decline publication of a paper even after it has

      been accepted if it becomes apparent that there are serious problems

      with the scientific content or violations of our publishing policies.

      Studies in Humans and Animals

      If

      the work involves the use of human subjects, the author should ensure

      that the work described has been carried out in accordance with The Code

      of Ethics of the World Medical Association (Declaration of Helsinki)

      for experiments involving humans. The manuscript should be in line with

      the Recommendations for the Conduct, Reporting, Editing and Publication

      of Scholarly Work in Medical Journals and aim for the inclusion of

      representative human populations (sex, age and ethnicity) as per those

      recommendations. The terms sex and gender should be used correctly.

      ......

      https://journals.lww.com/jno/Pages/instructionsforauthors.aspx


    验证码: 点击切换验证码